Neuropsychopharmacology at the new millennium: New industry directions

Neuropsychopharmacology

Volumn 20, Issue 2, 1999, Pages 99-105

  Tallman, John F ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

Anxiety disorders; Combinatorial chemistry; Depression; Genomics; High throughout screening; Schizophrenia

Indexed keywords

DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; MEDICAL GENETICS; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0033080767     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00104-3     Document Type: Editorial

References (27)

1. Anonymous (1996): 7Q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover. Am J Hum Genet 54:958-962
2. Bunin BA, Plunkett MJ, Ellman JA (1996): Synthesis and evaluation of three 1,4-benzodiazepine libraries. In Jung G (ed), Combinatorial Peptide and Nonpeptide Libraries, VCH, pp 405-424
3. Cho RJ, Fromont-Racine M, Wodicka C, Feuerbach B, Sterns L (1998): Parallel analysis of genetic selections using whole genome oligonucleotide arrays. Proc Nat Acad Sci USA 95:3752-3757
4. Cohen J (1997a): Developing prescriptions with a personal touch. Science 275:776
5. Cohen J (1997b): The genomics gamble. Science 275:762-767
6. Derisi J, Penlang L, Brown P, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM (1996): Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genetics 14:457-460
7. Epstein CJ (1995): The new dysmophology: Application of insights from basic developmental biology to the understanding of human birth defects. Proc Nat Acad Sci USA 92:8566-8573
8. Evans BE, Rittle KE, Bock MG, DiPardo RM, Friedinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J (1988): Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 31:2235-2246
9. Fodor SA (1997): Massively parallel genomics. Science 277: 393-395
10. Jurado LAP, Wang YK, Peoples R, Coloma A, Cruces J, Francke U (1998): A duplicated gene in the breakpoint of the 7q11.23 Williams-Beuren syndrome deletion encoded the initiator binding protein TF11-1 and BAP-135, a phosphorylation target of BTK. Human Mol Gen 7:325-334
11. Lecea LD, Kilduff TS, Peyron C, Gao X, Foye P, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik V, Bartlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998): The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Nat Acad Sc USA 95:322-327
12. Lifton RP (1996): Molecular genetics of human blood pressure variation. Science 272:676-680
13. Monsma FJ, Civelli O (1997): Dopamine receptors. In Browne MJ (ed), Recombinant Cell Surface Receptors: Focal Point for Therapeutic Intervention, London, R.G. Landes Co., pp 6-36
14. Moghaddam B, Adams BW (1998): Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352
15. Ni ZJ, Maclean D, Holmes CP, Gallop MA (1996): Encoded combinatorial chemistry: Binary coding using chemically robust secondary amine tags. Methods Enzymol 267 (Combinatorial Chemistry):261-272
16. Snyder SH, Lai MM, Burnett PE (1998): Immunophilins in the nervous system. Neuron 21:283-294
17. Tallman JF, Dahl S (1995): New drug design in psychopharmacology: The impact of molecular biology. In Bloom F, Kupfer S (eds), Psychopharmacology, the Fourth Generation of Progress, New York, Raven Press, pp 1861-1874
18. Tallman JF, Primus RJ, Brodbeck R, Cornfield L, Meade R, Woodruff K, Ross P, Thurkauf A, Gallager DW (1997): NGD 94-1: Identification of a novel high affinity antagonist at the human dopamine D4 receptor. J Pharm Exp Ther 282:1011-1019
19. Tartaglia LA (1997): The leptin receptor. J Biol Chem 272: 6093-6096
20. Wess J (1997): G-protein coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:346-354
21. Wang X, Ruffolo R, Feuerstein G (1996): mRNA Differential Display: Application in the Discovery of Novel Pharmacological Targets TIPS 17:276-279
22. Wang YK, Samos CH, Peoples R, Jurado LA, Nusse J, Francke U (1997): A novel human homolog of the drosophila frizzled wnt receptor gene binds wingless protein and is in the Williams syndrome deletion at 7q11.23. Hum Mol Genet 6:465-472
23. Weber BL (1996): Genetic testing for breast cancer. Scientific American (Science and Medicine) pp. 12-21
24. Weissman SM (1995): Genetic bases for common polygenic diseases. Proc Nat Acad Sci USA 92:8543-8544
25. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alish R, Matthews S, Nakura J, Miki T, Ouais S, Martin G, Mulligan J, Schellenberg GD (1996): Positional cloning of the Werner's syndrome gene. Science 272:258-262
26. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Freidman JM (1994): Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
27. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, Whitney M, Roemer K, Tsien RY (1998): Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279:84-88